Our Pipeline
First in Class Neutrophil Modifying Drug Candidates
Neutrophil Drug Manipulation
| Program | Discovery | Target Validation | In Vivo POC | Lead Selection | CMC | GLP Studies | IND |
|---|---|---|---|---|---|---|---|
|
IMYX-3 IBD
|
|
|
|
|
|
Q1 2026 |
|
|
IMYX-3 COPD
|
|
|
|
|
|
|
|
